Chlorthalidone News and Research

RSS
Guideline-recommended diuretic linked to more side effects than similar antihypertensive drug

Guideline-recommended diuretic linked to more side effects than similar antihypertensive drug

Antihypertensive drug associated with lower risk of gout

Antihypertensive drug associated with lower risk of gout

New statement provides detailed overview of how to diagnose, treat resistant hypertension

New statement provides detailed overview of how to diagnose, treat resistant hypertension

Pharmacotherapy reduces conduction system disease risk

Pharmacotherapy reduces conduction system disease risk

Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension

Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension

Chlorthalidone may reduce risk of death in patients with systolic hypertension

Chlorthalidone may reduce risk of death in patients with systolic hypertension

Antihypertensive drug therapy associated with longer life expectancy

Antihypertensive drug therapy associated with longer life expectancy

Takeda receives FDA approval for EDARBYCLOR to treat hypertension

Takeda receives FDA approval for EDARBYCLOR to treat hypertension

Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011

Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011

Takeda announces EDARBI availability in U.S. pharmacies for hypertension treatment

Takeda announces EDARBI availability in U.S. pharmacies for hypertension treatment

Takeda receives FDA approval for EDARBI to treat hypertension in adults

Takeda receives FDA approval for EDARBI to treat hypertension in adults

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

Study examines comparative value of different blood pressure lowering medications

Study examines comparative value of different blood pressure lowering medications

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Diuretic drug works best at reducing risk of heart failure in hypertension

Diuretic drug works best at reducing risk of heart failure in hypertension

Potassium loss from blood pressure drugs increases diabetes risk by 50%

Potassium loss from blood pressure drugs increases diabetes risk by 50%

Potassium loss caused by diuretics may explain higher risk of adult diabetes

Potassium loss caused by diuretics may explain higher risk of adult diabetes

Diuretic reduces risk for type of heart failure that affects women more often than

Diuretic reduces risk for type of heart failure that affects women more often than

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

Gene variations associated with effectiveness of blood pressure medications

Gene variations associated with effectiveness of blood pressure medications